Bluejay Therapeutics Alternatives & Competitors
12 companies similar to Bluejay Therapeutics — Developing innovative cures for infectious diseases with the first target indica...
Satellite Bio
Tackling some of humankind’s most elusive diseases with Tissue Therapeutics, a new categor...
Cambridge, United States
Nuvamid
A clinical stage biotech focused on the research and use of nucleotides, as therapeutics f...
Nyon, Switzerland
HepaRegeniX GmbH
Unlocking liver regeneration - delivering recovery
Tubingen, Germany
Solid Biosciences
#TogetherWeAreSolid
Boston, United States
Track all Bluejay Therapeutics competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Avidity Biosciences, Inc.
At Avidity, we are developing a new class of oligonucleotide-based therapies.
San Diego, United States
EUSA Pharma
Part of Recordati Rare Diseases, the business unit dedicated to rare diseases in the Recor...
Hemel Hempstead, United K...
Vico Therapeutics
Our mission is simple… bring innovative RNA modulating therapies to patients with severe,...
Leiden, The Netherlands
Grifols
Develops, produces and provides innovative healthcare services and solutions in more than...
YouthBio Therapeutics Inc.
Developing partial reprogramming gene therapies for Alzheimer’s and other diseases of agin...
Seattle, United States
Ultragenyx
Going Beyond Every Day
Novato, United States
Heartseed Inc.
Clinical-stage biotech company developing iPSC-derived highly purified ventricular cardiom...
Japan
BridgeBio
We move at the speed of patient need.
Palo Alto, United States
About Bluejay Therapeutics
Developing innovative cures for infectious diseases with the first target indication of chronic HDV infection
Development of therapeutics for liver diseases, Acquisition and integration of biotech companies, Research and development in chronic hepatitis delta virus treatment
Patients with liver diseases, Healthcare providers, Biotechnology investors, Medical professionals specializing in rare diseases
Biopharmaceutical, Infectious Diseases, Chronic HDV Infection, Hepatitis B, Functional Cure, Monoclonal Antibodies, IgG1 Anti-HBs, HBsAg Inhibitors, Small Molecule Inhibitors, Adaptive Immunity Restoration, Medical Innovation, Healthcare Solutions, Immunotherapy, Therapeutic Development, Biotechnology Startup
B2B
Licensing, Product Sales
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Bluejay Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Bluejay Therapeutics on 9 Jun 2026. The 12 companies listed here were last checked between 3 Mar 2026 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.